
Incarcerated postpartum individuals with opioid use disorder (OUD) are vulnerable to poor health outcomes, but care provision in custody for this population is variable. Addressing their distinct needs is crucial for improving correctional health care for postpartum people. In this paper wea document challenges jail staff experience providing postpartum care, and describe shifts in jail staff knowledge and practice changes related to postpartum care that may be attributable to participation in a training resource for perinatal OUD in corrections. We developed a web-based resource for jail staff called “Maternal Opioid Use Disorder Management and Care Resources in Custody” (MOMCARE). From May 2024 to January 2026, we conducted a 12-month pilot MOMCARE intervention at five jails of varying sizes across the United States. We collected facility data on postpartum services, provided ongoing facilitation activities, and conducted qualitative interviews with jail staff to explore postpartum care challenges and opportunities. Through a needs assessment survey and qualitative interviews with staff at baseline, we documented gaps and challenges in service provision for postpartum people. Through ongoing interviews and facilitation activities, jail staff reported promising practice changes including systematically screening for postpartum status at intake, streamlining lactation support processes, and assessing postpartum mental health using validated screening tools. Jail staff also learned that it is safe and recommended for postpartum people to breastfeed while on medications for OUD. Jail staff were receptive to educational and support tools. MOMCARE prompted jails to make changes that align with best practices for postpartum care.
To address postrelease overdose risk, a large urban county jail implemented an automated naloxone vending machine to provide no-cost, low-barrier naloxone at discharge. Through carceral and public health collaboration, staff installed a custom vending machine in the jail's discharge lobby to provide individuals 24/7 self-directed access to naloxone. In addition to the existing practice of providing naloxone units only to individuals clinically flagged for acute withdrawal at intake, machine-based distribution averaged 75 units monthly during the initial 4-month active phase and 100 units monthly during the 2024-2025 sustainment period. Overall, total jail-based distribution increased by 40% following implementation. These results demonstrate how interagency alignment can expand low-barrier naloxone access and support sustained distribution during community reentry.
Information on body mass index (BMI) fluctuations during multiyear incarceration is limited, with publications on BMI changes leading to reclassification even more sparse. This is particularly important because access to novel treatments, such as glucagon-like peptide-1 (GLP-1) therapies, in the United States depends on BMI classification rather than the exact BMI value. This retrospective analysis explores BMI classification changes over 2 years to assist public health interventions. The dataset included 30,693 individuals with at least two recorded height and weight measurements, accounting for 31, 299 incarcerations between January 1, 2018, and December 31, 2021 across 37 U.S. federal prisons. BMI classification changes were tracked and categorized as upward, downward, or unchanged using the Centers for Disease Control and Prevention BMI classification system. The analysis included descriptive statistics by age group, sex, race, ethnicity, and education, as well as adjusted logistic regression models. One-third of individuals experienced BMI classification changes. Females and individuals without a verified high school diploma/GED who were not participating in the GED program had 20% and 37%, respectively, higher odds of upward reclassification. These findings suggest the need for interventions tailored to address BMI classification changes upon incarceration to meet individual needs.
Retention in peer recovery programs is critical for individuals with opioid use disorder involved in the criminal justice system. This study examined predictors of one-month retention in the Empowered Communities Opioid Project, a peer recovery support program serving adults across five Virginia health districts. Baseline survey data from 255 participants enrolled between September 2022 and February 2025 were analyzed. Measures included demographic, social, economic, mental health, health care access, and substance use factors. Logistic regression models identified predictors of retention. Of the 255 participants, 127 (49.8%) were retained at one month. Program site was the strongest predictor of retention, with participants at Site 2 significantly less likely to be retained than those at Site 1 (odds ratio = 0.45, p = .004). Recent opioid use and prior overdose were also associated with lower retention.
Background: Hepatitis A is a vaccine-preventable infection which may lead to serious consequences, and which may spread among people experiencing homelessness or substance use disorder. Because these factors are highly prevalent in incarcerated populations, identifying susceptible groups and establishing high levels of immunity are crucial to reducing disease transmission and morbidity. Aim: To describe hepatitis A immunity and vaccination status in the California prison population and to identify predictors of susceptibility. Methods: This cross-sectional study used secondary data and employed descriptive, bivariate, and multivariable logistic regression analyses. Results: Among the 86,387 incarcerated adults in June 2024, 41.7% had received at least two doses of hepatitis A vaccine, 49.3% had an identified risk factor for HAV, and 47.2% had been tested by serology. The majority (83.1%) had evidence of immunity either by vaccination or seropositivity. Among those who underwent serological testing, 29.7% were seronegative. Independent predictors in an adjusted model of susceptibility included older age, being non-Hispanic, and being U.S.-born. Individuals with certain medical conditions were less likely to be susceptible. Conclusion: Although HAV immunity was high among the California prison population, the substantial prevalence of risk factors supports correctional facilities as an important venue for routine HAV vaccination.